Alexey Bogdanov

588 total citations
48 papers, 359 citations indexed

About

Alexey Bogdanov is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering. According to data from OpenAlex, Alexey Bogdanov has authored 48 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Biomedical Engineering. Recurrent topics in Alexey Bogdanov's work include Nanoplatforms for cancer theranostics (8 papers), Photodynamic Therapy Research Studies (8 papers) and RNA and protein synthesis mechanisms (7 papers). Alexey Bogdanov is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Photodynamic Therapy Research Studies (8 papers) and RNA and protein synthesis mechanisms (7 papers). Alexey Bogdanov collaborates with scholars based in Russia, United States and Belarus. Alexey Bogdanov's co-authors include Vladimir Moiseyenko, Fedor Moiseenko, Yuri L. Lyubchenko, Nikita Volkov, Alexander Y. Lushnikov, Nickolay A. Knyazev, Michael Dubina, Петр В. Сергиев, Mikhail N. Ryazantsev and Vitali M. Boitsov and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Alexey Bogdanov

38 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexey Bogdanov Russia 9 160 82 81 73 54 48 359
Leslie O. Ofori United States 9 286 1.8× 88 1.1× 85 1.0× 96 1.3× 77 1.4× 9 471
Allison S. Cohen United States 14 294 1.8× 73 0.9× 69 0.9× 95 1.3× 119 2.2× 27 525
Edmund R. Marinelli United States 13 288 1.8× 68 0.8× 187 2.3× 121 1.7× 63 1.2× 31 617
Margaret S. Cooper United Kingdom 13 197 1.2× 157 1.9× 79 1.0× 77 1.1× 29 0.5× 23 536
Santosh B. Salunke Taiwan 13 247 1.5× 87 1.1× 141 1.7× 25 0.3× 47 0.9× 18 468
Csilla N. Felsen United States 5 217 1.4× 47 0.6× 36 0.4× 150 2.1× 41 0.8× 6 431
Patrick L. Donabedian United States 14 119 0.7× 116 1.4× 60 0.7× 70 1.0× 20 0.4× 21 401
Adam Badar United Kingdom 11 112 0.7× 69 0.8× 64 0.8× 60 0.8× 11 0.2× 15 327
Edward A. Motea United States 14 562 3.5× 101 1.2× 55 0.7× 44 0.6× 64 1.2× 25 653

Countries citing papers authored by Alexey Bogdanov

Since Specialization
Citations

This map shows the geographic impact of Alexey Bogdanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexey Bogdanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexey Bogdanov more than expected).

Fields of papers citing papers by Alexey Bogdanov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexey Bogdanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexey Bogdanov. The network helps show where Alexey Bogdanov may publish in the future.

Co-authorship network of co-authors of Alexey Bogdanov

This figure shows the co-authorship network connecting the top 25 collaborators of Alexey Bogdanov. A scholar is included among the top collaborators of Alexey Bogdanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexey Bogdanov. Alexey Bogdanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zabrodskaya, Yana, Nickolay A. Knyazev, Alexey Bogdanov, et al.. (2024). Cell-penetrating peptide and cationic liposomes mediated siRNA delivery to arrest growth of chronic myeloid leukemia cells in vitro. Biochimie. 221. 1–12. 3 indexed citations
2.
Верлов, Н. А., et al.. (2024). Role of urinary tract microbiota and urine proteome in urolithiasis pathogenesis. Nephrology (Saint-Petersburg). 28(2). 85–93.
3.
Bogdanov, Alexey, et al.. (2024). Tumor alkalization therapy: misconception or good therapeutics perspective? – the case of malignant ascites. Frontiers in Oncology. 14. 1342802–1342802. 2 indexed citations
4.
5.
Bogdanov, Alexey, et al.. (2023). Evaluation of Narrow-band Imaging of Early Gastric Cancer. Bulletin of Science and Practice. 9(10). 172–175. 1 indexed citations
6.
Bogdanov, Alexey, et al.. (2022). Tumor acidity: From hallmark of cancer to target of treatment. Frontiers in Oncology. 12. 979154–979154. 100 indexed citations
7.
Moiseenko, Fedor, et al.. (2022). Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance. Current Treatment Options in Oncology. 23(12). 1664–1698. 1 indexed citations
8.
Bogdanov, Alexey, et al.. (2021). Antitumor efficacy of an isolated hind legperfusion with a pH-increased solution in thePliss’ lymphosarcoma graft rat model. SHILAP Revista de lepidopterología. 49(8). 541–549. 1 indexed citations
9.
Bogdanov, Alexey, et al.. (2021). Efficacy of first-line treatments for patients (pts) with advanced EGFR mutated NSCLC: Network meta-analysis of TKI monotherapy and combinations trials.. Journal of Clinical Oncology. 39(15_suppl). e21120–e21120. 1 indexed citations
10.
Knyazev, Nickolay A., et al.. (2021). Minimal PK/PD model for simultaneous description of the maximal tolerated dose and metronomic treatment outcomes in mouse tumor models. Cancer Chemotherapy and Pharmacology. 88(5). 867–878. 3 indexed citations
11.
12.
Vanić, Željka, Zora Rukavina, Suvi Manner, et al.. (2019). Azithromycin-liposomes as a novel approach for localized therapy of cervicovaginal bacterial infections. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Boitsov, Vitali M., Alexander V. Stepakov, Alexander S. Filatov, et al.. (2018). Concise Synthesis of Tryptanthrin Spiro Analogues with In Vitro Antitumor Activity Based on One-Pot, Three-Component 1,3-Dipolar Cycloaddition of Azomethine Ylides to Сyclopropenes. Synthesis. 51(3). 713–729. 31 indexed citations
14.
Knyazev, Nickolay A., et al.. (2018). Influence of electrostatic interactions on cell-penetrating peptide-small interfering RNA complex formation and intracellular delivery efficiency. Journal of Physics Conference Series. 1124. 31005–31005. 2 indexed citations
15.
Komarova, Ekaterina S., Ilya А. Osterman, Philipp I Pletnev, et al.. (2016). 2-Guanidino-quinazolines as a novel class of translation inhibitors. Biochimie. 133. 45–55. 16 indexed citations
16.
Korshunova, Galina A., et al.. (2015). Modeling interactions of erythromycin derivatives with ribosomes. Biochemistry (Moscow). 80(11). 1500–1507. 4 indexed citations
17.
Kasyanenko, Nina A., С. С. Абрамчук, И. В. Благодатских, et al.. (2003). Study of DNA complexation with platinum coordination compounds. 45(10). 960–968. 1 indexed citations
18.
Lushnikov, Alexander Y., Alexey Bogdanov, & Yuri L. Lyubchenko. (2003). DNA Recombination. Journal of Biological Chemistry. 278(44). 43130–43134. 32 indexed citations
19.
Bogdanov, Alexey, et al.. (1984). THE NATURE OF COVALENT LINKAGE BETWEEN RELAXATION PROTEIN AND COLE1 DNA IN THE RELAXATION COMPLEX. 10(4). 567–569. 1 indexed citations
20.
Vartapetian, Andrey B., Eugene V. Koonin, Konstantin Chumakov, Alexey Bogdanov, & Vadim I. Agol. (1982). INITIATION OF THE ENCEPHALOMYOCARDITIS VIRAL-RNA SYNTHESIS IN CELL-FREE SYSTEM AND THE PROBABLE PARTICIPATION OF VPG PROTEIN IN THIS PROCESS. Proceedings of the USSR Academy of Sciences. 267(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leslie O. Ofori Breakdown of academic impact, for papers by Allison S. Cohen Breakdown of academic impact, for papers by Edmund R. Marinelli Breakdown of academic impact, for papers by Margaret S. Cooper Breakdown of academic impact, for papers by Santosh B. Salunke Breakdown of academic impact, for papers by Csilla N. Felsen Breakdown of academic impact, for papers by Patrick L. Donabedian Breakdown of academic impact, for papers by Adam Badar Breakdown of academic impact, for papers by Edward A. Motea
Rankless by CCL
2026